Rapid Fire AFib: The Latest in Management Strategies

Image

What You Will Learn

  • Utilize advantages of early rhythm control

  • Optimization and dose adjustments for DOACs

  • Select patients for triple therapy, including duration and optimal agents

  • Identify indications of non-pharmacologic treatment for patients at high risk of bleeding

We are grateful to these distinguished Members of the American College of Cardiology who contributed to this collection:

 

Julia H. Indik, MD, PhD, FACC (Chair)

 

James V. Freeman, MD, FACC

 

Michael Robert Gold, MD, PhD, Facc

 

Tiffany Ying Hu, MD

 

Dharam J. Kumbhani, MD, SM, FACC

 

Nicholas Tan, MD

 

Cynthia M. Tracy, MD

 

Supported by an independent educational grant from: Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC | Page Launched: April 2022

Android App Download IOS App Download Powered By